Clinical Edge Journal Scan

Sarcopenia prevalence and risk in older RA patients


 

Key clinical point: Patients with rheumatoid arthritis (RA) who were ≥65 years old had a significantly increased risk of developing sarcopenia, particularly if they were men with poor nutritional status and long-standing disease.

Major finding: Sarcopenia was diagnosed in a higher proportion of patients with RA vs control individuals without RA (15.8% vs 3.9%; P = .014). Male sex ( P = .042), longer disease duration ( P = .012), and poorer nutritional status ( P = .042) were significant risk factors for the development of sarcopenia in older patients with RA.

Study details: Findings are from a cross-sectional study including 76 patients age 65 years with RA and 76 age- and sex-matched control individuals without RA.

Disclosures: This study was funded by Redes de Investigación Cooperativa Orientadas a Resultados en Salud, Spain, and other sources. The authors declared no conflicts of interest.

Source: Cano-García L et al. Sarcopenia and nutrition in elderly rheumatoid arthritis patients: A cross-sectional study to determine prevalence and risk factors. Nutrients. 2023;15:2440 (May 24). doi: 10.3390/nu15112440

Recommended Reading

After Yusimry’s steep discount, little clarity on future adalimumab biosimilar pricing
MDedge Rheumatology
Peresolimab shows efficacy as a new treatment approach for moderate-to-severe RA
MDedge Rheumatology
Antimalarials improve safety and persistence of bDMARD or JAKi treatment in RA
MDedge Rheumatology
Frailty raises risk for methotrexate discontinuation due to adverse events in RA
MDedge Rheumatology
Higher risk for herpes zoster with tofacitinib vs TNFi in RA
MDedge Rheumatology
Hydroxychloroquine confers dose-dependent survival benefits in elderly-onset RA
MDedge Rheumatology
Perioperative JAKi use seems safe in RA patients undergoing orthopedic procedure
MDedge Rheumatology
Depression and risk for death in RA: Is there a link?
MDedge Rheumatology
Ultrasound detects subclinical inflammation in RA patients with low or no disease activity
MDedge Rheumatology
Progressing joint damage: An indication to consider intensive treatment in RA patients in remission or LDA
MDedge Rheumatology